about
Chronic Q fever in the United StatesDevelopment of Liposomal Ciprofloxacin to Treat Lung InfectionsPrinciples of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agentsSurvey of laboratory animal technicians in the United States for Coxiella burnetii antibodies and exploration of risk factors for exposureFrom Q Fever to Coxiella burnetii Infection: a Paradigm Change.A super-spreading ewe infects hundreds with Q fever at a farmers' market in Germany.Seroprevalence of Q fever among human and animal in Iran; A systematic review and meta-analysis.Serosurvey and observational study of US Army Veterinary Corps officers for Q fever antibodies from 1989 to 2008Identification of novel Coxiella burnetii Icm/Dot effectors and genetic analysis of their involvement in modulating a mitogen-activated protein kinase pathway.Development of polyether urethane intravaginal rings for the sustained delivery of hydroxychloroquine.One-year follow-up of patients of the ongoing Dutch Q fever outbreak: clinical, serological and echocardiographic findings.Role for the CD28 molecule in the control of Coxiella burnetii infection.Maternofetal consequences of Coxiella burnetii infection in pregnancy: a case series of two outbreaksQ fever: a case with a vascular infection complicationZoonotic Bartonella species in cardiac valves of healthy coyotes, California, USA.Large regional differences in serological follow-up of Q fever patients in the Netherlands.Vaccination against Q fever for biodefense and public health indications.Deliberate release of biological agents.Persistent high IgG phase I antibody levels against Coxiella burnetii among veterinarians compared to patients previously diagnosed with acute Q fever after three years of follow-up.Chronic Q fever-related dual-pathogen endocarditis: case series of three patientsSpecific in vitro interferon-gamma and IL-2 production as biomarkers during treatment of chronic Q fever.SCID mouse model for lethal Q feverQ Fever: current state of knowledge and perspectives of research of a neglected zoonosis.Q fever endocarditis in Romania: the first cases confirmed by direct sequencing.Long-Term Serological Follow-Up of Acute Q-Fever Patients after a Large Epidemic.Q fever endocarditis in HIV-infected patientIdentification of risk factors for chronic Q fever, the Netherlands.Q fever in Greenland.Q Fever Knowledge, Attitudes and Vaccination Status of Australia's Veterinary Workforce in 2014.Differentiation of Acute Q Fever from Other Infections in Patients Presenting to Hospitals, the NetherlandsT cells are essential for bacterial clearance, and gamma interferon, tumor necrosis factor alpha, and B cells are crucial for disease development in Coxiella burnetii infection in mice.Microbiological challenges in the diagnosis of chronic Q fever.Estimation of acute and chronic Q fever incidence in children during a three-year outbreak in the Netherlands and a comparison with international literature.Prevalence of chronic Q fever in patients with a history of cardiac valve surgery in an area where Coxiella burnetii is epidemicAntimicrobial therapies for Q fever.Q Fever Presenting As Recurrent, Culture-negative Endocarditis with Aortic Prosthetic Valve Failure: A Case Report and Review of the Literature.Q fever endocarditis: a case report and review of the literatureHost pathways important for Coxiella burnetii infection revealed by genome-wide RNA interference screening.Large vessel vasculitis in a patient with acute Q-fever: A case report.Coxiella burnetii Infection in a Community Operating a Large-Scale Cow and Goat Dairy, Missouri, 2013.
P2860
Q24549147-AC9F6FB2-4CB1-44E5-A604-E6CFE6399DEAQ26764772-9A6CE3E2-2B70-421B-83D4-2D8CD964A6F8Q28384852-3B6A68E2-8C38-490A-9EA0-C95FEF937BDAQ30218134-816160C1-E0B2-4A15-8459-0A5439DA4939Q30241105-E96D1FAE-D2D4-4D8E-80CC-A295294990C3Q33259653-F64CCF20-DCA5-4EA0-85F6-9B1C572F2EF7Q33585323-2CCDBE43-AF58-43D8-BAD6-739A7D30D038Q34228534-BB7B0E29-A895-4DEC-AC58-66E0A594D6E6Q34298317-ACF88ACF-EC76-4DE2-974D-8EFDB5E4076AQ34353780-301C50CC-E77D-4C21-AECB-663B7FAEDC35Q34411765-5EB8B282-75F4-4B03-8E8B-AC3E51FEFDF8Q34491614-670D9D51-A159-47E2-92C2-533812AEFD27Q34515211-3C452F85-E092-45D6-90DD-94D4BB9C30E4Q34524431-364C6BBA-8FF5-4D1A-8054-6BAA573D152DQ34641315-61A970E6-7BB8-43F5-9F2F-1D0B66706ED1Q34663949-04308424-231C-48D1-9868-CBE43570DBF8Q34708529-CC74B4C0-0C50-4267-BDC8-B90C72B0D496Q34976844-CA6F1052-BCCF-4D16-B92F-61401EB7BF35Q34989557-4272BF3D-A711-42A5-8D5F-B9B953326075Q35067123-8FF7386D-F336-4A75-93F3-E25ABC822349Q35077274-B45961AA-E093-417C-B6CF-D5E3F926C502Q35165365-16AA36E0-7E53-4F1A-B1DA-65630E3FBF39Q35615074-CDCFC4E5-4A38-48D4-97DD-87B500DD7867Q35669582-9C24C9B5-63BD-48A8-933B-AA282556FEE3Q35687838-0C2794F5-D757-4D31-8EBF-07765F5D1A7AQ35756375-B6450ED1-958D-4384-9AD4-8BA79BD5A151Q35844643-7ABDE45E-A7B0-403E-8E6E-26B9B93576DFQ35877406-AEF8C48E-ACFA-4F6C-A6B3-D588F0B5E058Q35891438-510F51F7-CE6A-4D6F-A78B-0B9E297710B5Q35897008-3E13D728-4CAD-46AF-A73F-254581532771Q35913591-7E6D12B1-A564-4271-8E37-329F8BFC80E3Q35940706-957BC065-070E-45CD-B512-BBBA02AF7A9EQ36073935-598B8424-8348-41A4-B611-464C12056A7EQ36154677-1468129C-9D80-4522-954B-203D6C43C2EFQ36169968-FE2DB354-AC43-4B3F-B8D1-8A402F02048DQ36171286-B7B14E23-1239-41EE-A979-FC785E847B27Q36533905-252890E0-5B03-4A83-AF48-CE89B6C0AE72Q36576675-A43BC5F6-331D-400F-81F0-89F61F7124BBQ36604825-0B847D10-D801-4D5E-BDED-2BD4D0E41799Q36644415-97BF48E2-9C7E-4659-A399-1F7F90662BC6
P2860
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Risks factors and prevention of Q fever endocarditis.
@en
type
label
Risks factors and prevention of Q fever endocarditis.
@en
prefLabel
Risks factors and prevention of Q fever endocarditis.
@en
P2093
P2860
P356
P1476
Risks factors and prevention of Q fever endocarditis.
@en
P2093
P2860
P304
P356
10.1086/321889
P407
P577
2001-06-25T00:00:00Z